Edition:
United Kingdom

Novus Therapeutics Inc (NVUS.OQ)

NVUS.OQ on NASDAQ Stock Exchange Capital Market

4.92USD
17 Sep 2018
Change (% chg)

-- (--)
Prev Close
$4.92
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
25,631
52-wk High
$8.61
52-wk Low
$3.13

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.339
Mar '18 0.00 -0.362
FY 2017 Dec '17 0.00 -0.294
Sep '17 0.00 -0.428
Jun '17 0.00 -1.603
Mar '17 0.00 -0.428
FY 2016 Dec '16 0.00 -1.485
Sep '16 0.00 -3.686
Jun '16 0.00 -5.378
Mar '16 0.00 -4.545
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 2 0.00 0.00 0.00 --
Quarter Ending Dec-18 2 0.00 0.00 0.00 --
Year Ending Dec-18 2 0.00 0.00 0.00 --
Year Ending Dec-19 2 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Sep-18 2 -0.40 -0.38 -0.42 --
Quarter Ending Dec-18 2 -0.32 -0.22 -0.42 --
Year Ending Dec-18 2 -1.38 -1.22 -1.54 --
Year Ending Dec-19 2 -1.37 -1.14 -1.59 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.93 32.76
P/E High - Last 5 Yrs. -- 40.65 45.44
P/E Low - Last 5 Yrs. -- 23.69 24.26
Beta -- 0.90 0.89
Price to Sales (TTM) -- 3.94 5.75
Price to Book (MRQ) 1.43 4.88 5.00
Price to Tangible Book (MRQ) 1.55 5.70 6.57
Price to Cash Flow (TTM) -- 22.85 23.29
% Owned Institutions 52.52 1.23 2.21

Dividends

  Company industry sector
Dividend Yield -- 1.57 1.51
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.35 5.22
Payout Ratio(TTM) -- 45.85 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 2.27 8.01
Sales (TTM) vs TTM 1 Yr. Ago -- 4.77 5.64
Sales - 5 Yr. Growth Rate -- 9.94 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 70.19 17.61 20.61
EPS (TTM) vs TTM 1 Yr. Ago 62.18 -- --
EPS - 5 Yr. Growth Rate -- 9.75 10.66
Capital Spending - 5 Yr. Growth Rate -- 15.37 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.15 2.22
Current Ratio (MRQ) 7.86 2.94 3.03
LT Debt to Equity (MRQ) 1.05 10.03 12.51
Total Debt to Equity (MRQ) 1.05 14.07 16.85
Interest Coverage (TTM) -- 35.79 32.65

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.71 54.37
Gross Margin - 5 Yr. Avg. -- 52.10 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.48 10.68
Operating Margin (TTM) -- 14.31 4.32
Operating Margin - 5 Yr. Avg. -- 14.43 6.11
Pre-Tax Margin (TTM) -- 14.80 5.18
Pre-Tax Margin - 5 Yr. Avg. -- 14.82 6.51
Net Profit Margin (TTM) -- 11.05 1.48
Net Profit Margin - 5 Yr. Avg. -- 11.12 2.78
Effective Tax Rate (TTM) -- 23.22 23.11
Effective Tax Rate - 5 Yr. Avg. -- 23.48 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 952,974,954 860,372,597
Net Income/Employee (TTM) -2,630,375 112,117,037 101,206,889
Receivable Turnover (TTM) -- 5.72 5.87
Inventory Turnover (TTM) -- 2.63 3.41
Asset Turnover (TTM) 0.00 0.96 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -57.10 11.58 11.13
Return on Assets - 5 Yr. Avg. -- 12.95 12.40
Return on Investment (TTM) -67.10 15.07 14.61
Return on Investment - 5 Yr. Avg. -- 16.90 16.13
Return on Equity (TTM) -67.53 16.59 16.33
Return on Equity - 5 Yr. Avg. -- 17.97 17.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 16.37 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Novus Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 52.76%
# of Holders: 29
Total Shares Held: 4,970,874
3 Mo. Net Change: -732,630
# New Positions: 4
# Closed Positions: 3
# Increased Positions: 11
# Reduced Positions: 10
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.